Syndrome with alpha-thalassemia as a major feature

Syndrome with alpha-thalassemia as a major feature refers to a group of rare genetic conditions in which alpha-thalassemia — a disorder of hemoglobin production caused by reduced or absent synthesis of alpha-globin chains — occurs as a prominent clinical component alongside other syndromic features. This Orphanet grouping (ORPHA:232288) encompasses several distinct entities where alpha-thalassemia is not an isolated hematological finding but is instead part of a broader multisystem disorder. The most well-known conditions within this category include ATR-X syndrome (alpha-thalassemia X-linked intellectual disability syndrome) and ATR-16 syndrome (alpha-thalassemia with intellectual disability due to chromosome 16p13.3 deletions), among others. The body systems affected vary depending on the specific underlying syndrome but commonly include the hematological system (manifesting as microcytic hypochromic anemia due to alpha-thalassemia), the central nervous system (intellectual disability of varying severity, developmental delay), and craniofacial structures (dysmorphic facial features). Additional features may include genital anomalies, skeletal abnormalities, and growth retardation. The severity of alpha-thalassemia in these syndromes typically ranges from mild (HbH inclusions detectable on blood film) to moderate, and is often milder than the anemia seen in classical alpha-thalassemia major. Management is multidisciplinary and largely supportive, tailored to the specific syndrome diagnosed. Hematological management may include monitoring of hemoglobin levels, folic acid supplementation, and occasionally blood transfusions during periods of hemolytic crisis or intercurrent illness. Developmental support, speech therapy, and special education services are important for individuals with intellectual disability. Genetic counseling is essential for affected families, and molecular genetic testing is used to confirm the specific diagnosis within this group of syndromes.

Common questions about Syndrome with alpha-thalassemia as a major feature